Objective: To preliminarily explore the significance of intelligent devices in improving the compliance of inhaled corticosteroid (ICS) in children with recurrent wheezing. Methods: Children with recurrent wheezing (≤5 years old) admitted into our hospital from Sept. 2017 to Sept. 2018 and received long-term asthma control drug therapy were extracted. According to the willingness of the guardians

all children were divided into the intelligent group and the conventional group under the condition of family atomization. Among them

the intelligent group installed intelligent devices to implement remote monitoring and management

that is

according to the clinical monitoring and evaluation elements of childhood asthma management

the asthma housekeeper APP based on IOS and Android mobile operating system was developed

and the ICS tracker was provided. Intelligent devices connected with BLE 4.0 were used for data exchange

assessing the condition of the children and realizing timely communication

medication reminder

disease exchange and intervention. Children in both groups were given budesonide inhalation treatment and were followed up by WeChat for 6 months with monthly assessments. Treatment compliance

asthma control rate

scores of the modified Chinese version of the Pediatric Respiratory and Asthma Control Test (TRACK)

outpatient and emergency department visits

respiratory infections

antibiotics and systemic glucocorticoids were compared. Results: Follow-up was completed in 33 cases in the intelligent group and 37 cases in the conventional group. After follow-up of 6 months

the medication compliance rate of the intelligent group was 57.6%

higher than that of the conventional group (32.4%). The complete control rate of asthma-like symptoms was 63.6%

higher than that of the conventional group (48.6%). And the symptom control rate of TRACK score was 69.7%

higher than that of the conventional group (45.9%). The total number of outpatient and emergency visits

the total number of respiratory tract infections

the application of antibiotics and systemic hormone in the intelligent group were lower than those in the conventional group (P<0.05). Conclusion: The application of intelligent devices can improve the compliance of ICS treatment in children with recurrent wheezing

improve the asthma-like symptoms in children

promote the control level of asthma

and reduce the number of outpatient and emergency visits

the number of respiratory infections and the application of antibiotics and systemic glucocorticoids

which is worthy of clinical promotion and application.